Exercise for Improved Cognition and Cardiometabolic Health
Trial Summary
Will I have to stop taking my current medications?
The trial requires that you stop taking certain medications, specifically those for weight suppression and those that affect heart rate and rhythm. If you are on these medications, you would need to discontinue them to participate.
What data supports the effectiveness of the treatment Exercise, Physical Activity, Workout, Fitness Training for improved cognition and cardiometabolic health?
Is exercise generally safe for humans?
Exercise is generally safe for humans, but there can be some risks, especially for people who are not used to physical activity or have existing health issues. Most adverse events are minor, like muscle injuries, and serious problems are rare. It's important to start slowly and gradually increase intensity to minimize risks.678910
How does exercise as a treatment for cognition and cardiometabolic health differ from other treatments?
Exercise is unique because it improves cognition and cardiometabolic health by enhancing brain function and energy metabolism, and it does so without the need for medication. It works by increasing brain-derived neurotrophic factor, which supports brain health and plasticity, and it can be combined with dietary changes for even greater benefits.1112131415
What is the purpose of this trial?
Dementia is a leading cause of death in the United States among aging adults. Brain insulin resistance has emerged as a pathologic factor affecting memory, executive function as well as systemic glucose control. Regular aerobic exercise decreases Alzheimer's Disease (AD) risk, in part, through changes in brain structure and function. However, there is limited data available on how exercise impacts brain insulin resistance in aging. This study will test the effect of acute exercise on brain insulin sensitivity in middle-aged to older adults. The study will also examine cognition and cardiometabolic health in relation to brain insulin sensitivity.
Research Team
Steven K Malin, PhD
Principal Investigator
Rutgers University - New Brunswick
Eligibility Criteria
This trial is for men and women aged 40-80 who are not very active (less than 150 minutes of exercise per week), have a BMI between 25 and 45, but aren't pregnant or nursing. It's not for those with serious health issues, recent smokers, or people on certain medications that affect weight or heart rate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including MRI arterial spin labeling and cognitive testing
Intervention
Participants either rest or exercise at medium to hard intensity for 1 hour
Follow-up
Participants are monitored for changes in brain insulin sensitivity, cognition, and cardiometabolic health
Treatment Details
Interventions
- Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor